Ciba Vision, Acuvue and Bausch & Lomb Contact Lenses - A Three Way Battle For the Future

Bausch & Lomb Contact lenses have long beenastigmatism. The last division of the company is its
one of the most recognised names in optical care.cataract and vitreoretinal surgery division. This part of
However, the market is becoming more difficult allthe company manufactures tools for use in surgery
the time. Countless firms now have entered thefor various eye related conditions.
market. They offer all sorts of different products,Lens care is more developed than most contact lens
but the main battle remains between the company'smanufacturers lens care divisions, Acuvue for
long term rivals Acuvue and Ciba vision. As theyexample doesn't manufacture contact lens solutions
struggle for control of innovative new technologies,at all. The company however manufacture ReNu
which of these three giants is best placed tosolutions which are popular multipurpose solutions that
succeed?are currently trying to recover from a product recall
Unlike most contact lens manufacturers it is only partin 2006. They also manufacture lens care for rigid
of the larger brand. For the manufacturer Ciba Vision,lenses under the brand name Boston which puts
for example, they are part of a larger pharmaceuticalBausch & Lomb lenses against smaller
company, Novartis, but the brand Ciba Vision onlymanufacturers such as Lucid, as the soft lens
refers to contact lens manufacturing and solutions.manufacturers tend not to make rigid lenses.
Let's look at the larger company first. It divides itsRecently Bausch & Lomb contact lenses have
business into five core areas, two of which arebeen in competition both in the market and in the
contact lenses and solutions. The other areas arecourt room over the development of silicon hydrogel
pharmaceuticals for eye conditions such ascontact lenses branded by Bausch and Lomb as
conjunctivitis, cataract and vitreoretinal surgeyPurevision. Ciba Vision's patent rights in the USA for a
instruments and refractive laser surgery tools.time prohibited Purevision contacts being sold there
The pharmaceutical division of the companyuntil agreement was reached. Acuvue's Oasys and
manufactures a number of eye drop treatments suchCooper Vision's Biofinity are in similar situations.
Besivance an anti bacterial used to treat conjunctivitis.The company is now no longer a public company
The smallest part of the company, it's refractivelisted on the NYSE. It was taken over by the private
surgery division, manufactures equipment forequity firm Warburg Pincus. However core to success
corrective eye surgery such as the often advertisedof Bausch & Lomb Contact lenses will be the
LASIK surgery. This surgery reshapes a person'squestion of whether its products can stand up to the
cornea to adjust for myopia, hyperopia orcompetition.